Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50 participants
OBSERVATIONAL
2017-05-10
2017-12-24
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cognitive Disorders in Hereditary Spastic Paraplegia Type 4
NCT06260982
Phenotypes, Biomarkers and Pathophysiology in Hereditary Spastic Paraplegias and Related Disorders
NCT03981276
Interaction of the Cognitive and Sensory-cognitive Tasks With Postural Stability in Individuals With Stability Disorders
NCT05024240
Resting Postural Tremor in Multiple Sclerosis
NCT04405479
Cognitive Function Assessment in Patients With Focal Brain Injury
NCT04182087
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SPG4 patients
CANTAB
CANTAB Cognitive Assessment (tablet based cognitive testing from CAMCOG)
MOCA
Montreal cognitive assessment (MOCA) in German
Healthy controls
CANTAB
CANTAB Cognitive Assessment (tablet based cognitive testing from CAMCOG)
MOCA
Montreal cognitive assessment (MOCA) in German
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CANTAB
CANTAB Cognitive Assessment (tablet based cognitive testing from CAMCOG)
MOCA
Montreal cognitive assessment (MOCA) in German
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18 to 70 years
* Written, informed consent
Exclusion Criteria
* Presence of gait disorder or other neurological condition (for healthy controls)
18 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital Tuebingen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Dr. Ludger Schöls
Prinicipal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ludger Schöls, Prof. Dr.
Role: PRINCIPAL_INVESTIGATOR
University Hospital Tübingen, Center for Neurology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Tübingen, Center for Neurology
Tübingen, , Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Rattay TW, Boldt A, Volker M, Wiethoff S, Hengel H, Schule R, Schols L. Non-motor symptoms are relevant and possibly treatable in hereditary spastic paraplegia type 4 (SPG4). J Neurol. 2020 Feb;267(2):369-379. doi: 10.1007/s00415-019-09573-w. Epub 2019 Oct 23.
Related Links
Access external resources that provide additional context or updates about the study.
Article Link (DOI)
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Cognition_SPG4
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.